Please login to the form below

Not currently logged in
Email:
Password:

Cidara Therapeutics makes senior appointments

Paul Daruwala and James Balkovec join the biotech

edit-Cidara-Paul-DaruwalaBiotech Cidara Therapeutics has named Paul Daruwala as chief commercial officer and James Balkovec as senior VP of research.

Daruwala (pictured) has over 22 years of experience in the biopharma industry and will lead Cidara's commercial and business development strategies and execution.

He joins from BMS, where he served as VP of the US viral hepatitis franchise, which is responsible for leading the US launch platform in hepatitis C and running the hepatitis B business for Baraclude.

Prior to BMS, Daruwala spent 18 years at Merck in a range of US and global commercial leadership roles in areas including anti-inflammatory products, business development and sales management.

Balkovec has over 28 years of experience in the biopharma industry and has extensive experience within drug discovery. He also joins from Merck, where he has served as senior scientific director and team leader, managing programmes in areas including infectious disease, metabolic syndrome and thrombosis disease.

Balkovec has helped bring more than a dozen development candidates into clinical development, including the first approved echinocandin antifungal drug Cancidas (caspofungin), which he is additionally co-inventor of.

Cidara focuses on the discovery, development and commercialisation of novel anti-infectives for the treatment of diseases that are not adequately addresses by current available therapies.

2nd March 2015

From: Research, Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

Here at Cuttsy+Cuttsy, we believe in making the world a better place by bringing trusted, accessible information to all and...

Latest intelligence

Is communication failing us?
Compelling people to care in a world oversaturated with news and information...
Are your field teams ready to excel in the new era?
A qualitative research approach to help you critically assess post-pandemic learnings and ignite the potential of meaningful interactions with HCPs....
5 Healthcare Marketing Blunders | How To Avoid Them.
Here are 5 healthcare marketing blunders and how best to avoid them....